Bortezomib-dexamethasone as maintenance therapy or early retreatment at biochemical relapse versus observation in relapsed/refractory multiple myeloma patients: a randomized phase II study

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Cancer J
Autors principals: Mina, Roberto, Belotti, Angelo, Petrucci, Maria Teresa, Zambello, Renato, Capra, Andrea, Di Lullo, Giacomo, Ronconi, Sonia, Pescosta, Norbert, Grasso, Mariella, Monaco, Federico, Cellini, Claudia, Gobbi, Marco, Ballanti, Stelvio, de Fabritiis, Paolo, Mosca-Siez, Maria Letizia, Marchetti, Monia, Liberati, Anna Marina, Offidani, Massimo, Giuliani, Nicola, Ria, Roberto, Musto, Pellegrino, Romano, Alessandra, Sonneveld, Pieter, Boccadoro, Mario, Larocca, Alessandra
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2020
Matèries:
Correspondence
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7234990/
https://ncbi.nlm.nih.gov/pubmed/32424154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41408-020-0326-1
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars